Dr Eva Baxter joined QCGC Research in January 2018. Eva completed her PhD in Oncology at the University of Edinburgh in 2012. Eva is a Senior Research Fellow and Team Leader of our biomarker and molecular research program. This program focuses on discovering and validating biomarkers, aiming to improve diagnosis, treatment response prediction, and personalised therapeutic strategies. By combining molecular science with clinical trials, our biomarker program bridges the gap between laboratory findings and patient care to drive advancements in precision medicine for women with gynaecological cancer.